Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
NIMESULIDE
Helsinn Birex Pharmaceuticals Limited
3 %w/w
Gel
1999-12-10
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aulin 3% w/w Gel. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Aulin 3% w/w gel contains 3% w/w nimesulide (1 g of gel contains 30 mg of nimesulide). Excipients: Methyl parahydroxybenzoate 0.80% w/w Propyl parahydroxybenzoate 0.02% w/w For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Gel. Opalescent, pale yellow gel. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic relief of pain associated with sprains and acute traumatic tendinitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults: Nimesulide 3% w/w gel (usually 3 g, corresponding to a line 6-7 cm long) should be applied in a thin layer to the affected area 2-3 times daily and massaged until it is completely absorbed. Duration of treatment: 7 – 15 days. Children under 12 years: Nimesulide 3% w/w gel has not been studied in children. Therefore, safety and efficacy have not been established and the product should not be used in children (see section 4.3)_._ 4.3 CONTRAINDICATIONS Known hypersensitivity to nimesulide or to any other excipients in the gel. Use in patients in whom aspirin, or other medicinal products inhibiting prostaglandin synthesis, induced allergic reactions such as rhinitis, urticaria or bronchospasm. Use on broken or denuded skin or in the presence of local infection. Simultaneous use with other topical creams. Use in children under 12 years. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Nimesulide 3% w/w gel should not be applied to skin wounds or open injuries. Nimesulide 3% w/w gel should not be allowed to come into contact with the eyes or mucous membranes; in case of accidental contact, wash immediately with water_._ The product should never be taken by mouth. Hands should be washed after apply Read the complete document